| Product |
CAS |
Molecular formula |
More |
| N-(benzimidazol-2-yl)-5-chloro-1-indanylamine |
875755-16-1 |
C16H14ClN3 |
More |
| N-(benzimidazol-2-yl)-5-bromo-1-indanylamine |
875755-17-2 |
C16H14BrN3 |
More |
| N-(benzimidazol-2-yl)-4-chlorobenzhydrylamine |
875755-20-7 |
C20H16ClN3 |
More |
| N-(benzimidazol-2-yl)-4-methyl-1,2,3,4-tetrahydro-1-naphthylamine |
875755-41-2 |
C18H19N3 |
More |
| 7-(1-methyl-piperidin-4-yloxy)-chromen-2-one |
881387-60-6 |
C15H17NO3 |
More |
| 7-(2,2,6,6-tetramethyl-piperidin-4-yloxy)-chromen-2-one |
881387-65-1 |
C18H23NO3 |
More |
| 7-(1,2,2,6,6-pentamethyl-piperidin-4-yloxy)-chromen-2-one |
881387-63-9 |
C19H25NO3 |
More |
| N-[1-(4-chlorobenzyl)benzimidazol-2-yl]-4-chlorobenzylamine |
899809-03-1 |
C21H17Cl2N3 |
More |
| [2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine |
1026699-98-8 |
C16H19N5 |
More |
| cyclopropyl-[2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-amine |
910465-71-3 |
C16H17N5 |
More |
| [2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-phenyl-amine |
910465-94-0 |
C19H17N5 |
More |
| cyclohexyl-(2-pyrazol-1-yl-quinazolin-4-yl)-amine |
910535-81-8 |
C17H19N5 |
More |
| [2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-pyridin-2-yl-amine |
910465-64-4 |
C18H16N6 |
More |
| 2-(3,5-dimethyl-pyrazol-1-yl)-4-piperidin-1-yl-quinazoline |
910465-76-8 |
C18H21N5 |
More |
| benzyl-[2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-amine |
910465-78-0 |
C20H19N5 |
More |
| [2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-m-tolyl-amine |
910465-54-2 |
C20H19N5 |
More |
| [2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-p-tolyl-amine |
910465-53-1 |
C20H19N5 |
More |
| [2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-o-tolyl-amine |
910465-55-3 |
C20H19N5 |
More |
| (2-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-amin |
910465-48-4 |
C19H16ClN5 |
More |
| (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-amin |
910465-46-2 |
C19H16ClN5 |
More |
